Argenica Therapeutics Ltd

AGN

Company Profile

  • Business description

    Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. ItsĀ ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

  • Contact

    117 Broadway
    Unit 4
    NedlandsWA6009
    AUS

    T: +61 893293396

    https://www.argenica.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,821.4043.500.50%
CAC 407,878.46111.751.44%
DAX 4024,549.56342.651.42%
Dow JONES (US)44,458.30217.540.49%
FTSE 1008,867.0212.840.15%
HKSE23,892.32255.75-1.06%
NASDAQ20,611.34192.870.94%
Nikkei 22539,623.95197.33-0.50%
NZX 50 Index12,780.1111.500.09%
S&P 5006,263.2637.740.61%
S&P/ASX 2008,580.4041.800.49%
SSE Composite Index3,493.054.43-0.13%

Market Movers